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Protein interactions are crucial in most biological processes. Several in silico methods have been recently developed to predict
them. This paper describes a bioinformatics method that combines sequence similarity and structural information to support
experimental studies on protein interactions. Given a target protein, the approach selects the most likely interactors among the
candidates revealed by experimental techniques, but not yet in vivo validated. The sequence and the structural information of the
invivoconﬁrmedproteinsandcomplexesareexploitedtoevaluatethecandidateinteractors.Finally,ascoreiscalculatedtosuggest
the most likely interactors of the target protein. As an example, we searched for GRB2 interactors. We ranked a set of 46 candidate
interactors by the presented method. These candidates were then reduced to 21, through a score threshold chosen by means of a
cross-validation strategy. Among them, the isoform 1 of MAPK14 was in silico conﬁrmed as a GRB2 interactor. Finally, given a
set of already conﬁrmed interactors of GRB2, the accuracy and the precision of the approach were 75% and 86%, respectively. In
conclusion, the proposed method can be conveniently exploited to select the proteins to be experimentally investigated within a
s e to fp o t e n t i a li n t e r a c t o r s .
1.Introduction
Proteins rarely perform their biological functions inde-
pendently, since they usually interact with each other. In
fact, most of the biological activities require the creation
of protein complexes. As a consequence, the diﬀerent
levels of complexity of the biological systems are not
exclusively determined by the number of proteins of an
organism, but also by the number of their interactions.
Many experimental methods have been developed to study
protein interactions, such as the two hybrid system in
yeast,theaﬃnitypuriﬁcationfollowedbymassspectrometry
and the phage display libraries [1–4]. The use of these
techniques led to the creation of many databases containing
a great number of protein-protein interactions, such as
the Database of Interacting Proteins (DIPs), the General
Repository for Interaction Datasets (BioGRIDs), the Human
Protein Reference Database (HPRD), and the Biomolecular
Interaction Network Database (BIND) [5–8]. Because of the
high amount of false positives and false negatives resulting
from the application of these experimental approaches on a
large scale, such data repositories must be cautiously used.
Once a list of candidates is obtained, it is necessary to
analyze in vivo every possible interactor by expensive, time-
consuming, and labour-intensive experimental techniques
in order to validate the in vitro experimental result. For
this reason, in silico methods for the prediction of protein
interactions are considered valid tools to reduce the number
of candidates [9].
Two main computational approaches, based on sequence
similarityandstructuralmodelling,havebeenappliedforthe
prediction of protein interactions. The former is based on2 Journal of Biomedicine and Biotechnology
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Figure 1: The Bioinformatics strategy for protein interaction prediction.
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Figure 2: Hydrogen bond geometrical structure scheme. The
distance (d) between a donor (D) and an acceptor (A) and the
resulting angles σ, β, θ and σ are reported.
the selection of potential interacting partners on the basis of
the sequence similarity with conﬁrmed interactors [10–13].
This approach is based on the “homology modelling” prin-
ciple: similar protein sequences, sharing similar structures,
shouldalsosharesimilarinteractants[14].Amongsequence-
similarity based methods, one of the most widely used is
the “mirror tree” approach, based on the assumption that
interacting protein pairs are likely to evolve in a correlated
fashion [15, 16]. The latter set of approaches is based on
the properties of the three-dimensional structures of the
proteins, generally referred to as docking methods; these
methods exploit surface complementarity and electrostatics
properties to predict reliable structural complexes [17–25].
Although both these approaches are based on strong
theoretical and experimental data, they exhibit some lim-
itations. The ﬁrst approach might fail to predict protein
interactions, since a protein complex might be subjected to
ad i ﬀerent selection pressure than each single constituting
protein during evolution [26, 27]. For this reason, all the
structural details of a protein interaction become important
to determine the aﬃnity and the speciﬁcity of protein inter-
actions. Docking methods, in fact, analyze the interactions
at a three-dimensional level and are therefore considered to
be more accurate, also evaluating the biophysical parameters
of the interaction sites [28]. However, docking methods
are generally limited by the lack of the structures for the
majority of the proteins and by incomplete bio-physical
interaction knowledge [29, 30]. For these reasons, at present,
an integration of the two approaches is essential to better
predict putative interacting proteins [31–33].
The aim of this work is to design a knowledge-based
tool that can integrate the two approaches described above.
In particular, considering a target protein, we ﬁrst select a
set of the candidate interactors already obtained from other
experimental results, but not yet in vivo validated. Then, we
exploit the sequence and the structural information on in
vivo conﬁrmed interacting proteins and complexes, to ﬁnally
select the most reliable partners of the target protein.
2.MaterialsandMethods
The proposed bioinformatics approach is summarized in
Figure 1. The algorithm predicts the protein interactors ofJournal of Biomedicine and Biotechnology 3
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Figure 3: Three-dimensional structures of ERK2 (a) and MAPK14 (b) human proteins from PDB database (PDB ﬁles 2E14 and 1A9U,
resp.). Critical residues and their positions within the two proteins are reported.
a speciﬁc target protein (TP) relying on the following infor-
mation: (i) a list of potential interactors, already obtained
from other experimental results, but not in vivo validated;
(ii)invivoconﬁrmedinteractors;and(iii)three-dimensional
complex structures involving TP.
The approach follows ﬁve steps:
2.1.DatabaseSearch. Knownstructurescomplexesinvolving
TP are searched in public available databases, speciﬁcally
the Protein Data Bank (PDB) and the Protein Quaternary
Structure (PQS). First, TP interactors are searched in the
Human Protein Reference Database (HPRD) [7, available at
http://www.hprd.org/]. Then, two collections of TP interac-
tors are generated: conﬁrmed and validated in vivo (CINT)
and potential in vitro discovered (PINT). The CINT group
also includes TP interacting chain sequences, extracted from
PDB and PQS databases.
2.2. Alignment with the Conﬁrmed Interactors: Score1 and
Score2. PINT and CINT related sequences are globally
aligned using the Needleman and Wunsch algorithm with
the matrix BLOSUM50 and ﬁxing the penalties for row and
column gaps both equal to −8[ 34]. The score of the best
alignment of each I ∈ PINT is the ﬁrst element of the score
function (Score1(I)).
CINT aminoacid conservation with known protein
structures is evaluated using the ConSurf tool [35]. PINT
sequences are then aligned with the conserved regions
of CINT members, using the Needleman and Wunsch
algorithm, thus computing the second component of the
score (Score2(I)).
2.3. Extraction of the Interaction Motifs from the Protein
Complexes. The aminoacids at the interface binding sites
belonging to chains interacting with TP are retrieved on
the basis of the information on known protein complexes.
These interacting aminoacids are exploited to build a set
of interacting motifs, which are then searched within the
PINT members for the calculation of the third and fourth
components of the score function (Score3(I)a n dS c o r e 4(I)).
These steps of the methods are described in details in the
following sections.
2.3.1. Finding the Interacting Aminoacids by Looking at the
Intermolecular Distances. Using the Cartesian coordinates of
thecomplexesinvolvingTP,reportedinPDBﬁles,weidentify
putativeTPinteractingproteins.Foreveryinteractor,weﬁnd
the interacting aminoacids between TP and the interactor
chains: these residues are deﬁned as “centres of bond”.
I no r d e rt or e d u c et h ec o m p u t a t i o n a lb u r d e ni n v o l v e di n
the identiﬁcation of the interacting residues, we primarily
select the aminoacids at the protein interfaces. In detail,
we ﬁrst look for the amino acids that were less than 15
 
˚ A
far from one residue of the target chain. Then, for each
interactor, we consider as interface residues also those closer
than 10
 
˚ A to the aminoacids already found. In this step,
the distance between two aminoacids is calculated as the
distance between the α carbon atoms. Once the interfaces are
deﬁned, we search for the interacting aminoacids, deriving
from disulfur bridges, hydrogen bonds and salt bridges
electrostatic interactions. The following aspects are taken
into consideration:
(i) A cysteine sulfur bridge satisﬁes the following geo-
metrical constraints [36]: the two sulfur atoms (SG,
according to PDB nomenclature) must be 2–2.1
 
˚ Af a r
and the distance between the β carbon of a cysteine
and the sulfur atom of the other cysteine is set to 3–
3.1
 
˚ A.
(ii) For hydrogen bonds, the distances between the
acceptor and donor are computed. As shown in
Figure 2,thedistance(d)betweenadonor(D)andan
acceptor (A) should be less than 3.5
 
˚ A and the angle
σ should be less than π/2. Because the majority of4 Journal of Biomedicine and Biotechnology
Table 1: List of the atoms considered as acceptors and donors. For
both classes, the 3-letter codes of the amino acids, the symbol used
in the PDB ﬁles of the considered atom, and the maximum number
of hydrogen bonds of atom are reported.
Acceptors Donors
all O 1 all N 1
ASP OD1 2 HIS NE2 1
ASP OD2 2 HIS ND1 1
GLU OE1 2 LYS NZ 3
GLU OE2 2 ASN ND2 2
GLN OE1 1 GLN NE2 2
ASN OD1 1 ARG NE 1
SER OG 1 ARG NH1 2
THR OG1 1 ARG NH2 2
TRP NE1 1
SER OG 1
THR OG1 1
TYR OH 1
the PDB ﬁles do not contain the coordinates of the
hydrogen atoms, we do not consider the other three
geometrical features of the bond (r<2.5
 
˚ A, β>π / 2
and θ>π / 2) [37, 38]. Moreover, we deﬁne the
maximum number of hydrogen bonds that an atom
can form (as showed in Table 1), following the results
of a statistical analysis reported by McDonald and
Thornton [39]. If a residue overtook the maximum
number of bonds, we considered only those with the
lowest distances between acceptor and donor.
(iii) Salt bridges are electrostatic interactions between
residues with opposite charges. The negatively
charged atoms at physiological pH are OD1 and
OD2 of asparagine, and OD1 and OE2 of glutamic
acid. The positively charged ones are NH1, NH2 of
arginine and NZ of lysine. For a salt bridge between
two residues with opposite charges, the distance
between the charged atoms is set to be less than 3.5
 
˚ A
[36].
2.3.2. Enlargement of the Center of Bond. Because of the
folding of the primary structure, two residues that are
neighboursonthesurfaceofthethree-dimensionalstructure
can be far apart in the protein sequence. This explains
why the interacting amino acids are often spread in the
protein linear sequence, so that we can ﬁnd them completely
isolated. Moreover, although the interacting amino acids
are the most important components of the interaction, also
the neighbouring residues may eﬀectively contribute. For
this reason, we enlarge the “centre of bond” considering
the neighbouring residues with the same hydropathy of the
center of bond and then adding the so called proximal amino
acids. Hydropathy and proximal amino acids were computed
as follows.
Table 2: Example of a center of bond enlargement. The columns
show the amino acid one-letter code, the residues coordinates, the
statusof proximitywith respectto thepatternchain inthecomplex,
the status of hydropathy (1 hydrophobic, 0 hydrophilic) and the
secondary structure (H = alpha chain; L = loop) of every amino
acid around a center of bond. The center of bond is represented
by the amino acids within the bold lines (i.e., S and N); the grey-
highlighted rows are the results of the symmetrical enlargement
due to hydropathy, while the amino acid reported in italic (V) are
grouped because of its proximity to the opposite chain.
Amino acid Position Proximity Hydropathy Sec.Struct.
V4 6 0 1
F4 7 0 1
V 48 11H
P4 9 0 0 H
K5 0 0 0 L
S5 1 0 0 L
N5 2 0 0 L
R5 3 0 0 L
K5 4 0 0 L
V5 5 0 1
I5 6 0 1
(i) We calculate the hydrophobic and the hydrophilic
regions of the proteins, using the hydropathy scale
of Kyte-Doolittle [40]. In particular, we set to 1
every amino acid with a positive value in the
scale (hydrophobic residues) and to 0 those having
negative values (hydrophilic residues).
(ii) Then, in addition to directly interacting residues, we
also consider those that do not interact, but are closer
than 4.2
 
˚ A to the corresponding ones of the TP chain,
deﬁned as “proximal aminoacids”. To calculate the
distances, we consider the most external atoms of the
backbone of each amino acid.
Table 2 reported an example of the centre of bond enlarge-
ment process.
(1) If the center of bond (i.e., SN) is in a hydrophilic
region, we perform a symmetrical enlargement, until
a hydrophobic amino acid is found (i.e., PK and RK).
(2) Then the proximal amino acids adjacent to the result
of the enlargement (i.e., PKSNRK) is added (i.e., V
at position 48) As a result, it is possible to group two
or more adjacent centers of bond. We deﬁne a set of
one or more grouped centers of bond as a “binding
site.”Thesetofbindingsitesbelongingtoaninterface
between two chains is denoted as “interacting site”.
2.3.3. Building the Interacting Motifs. For each binding site,
we extract “interacting motif” through the analysis of
secondaryandtertiarystructuresoftheproteins;thesemotifs
are then searched within the PINT sequences.
To analyse the sequence motifs, we divide the aminoacids
into six classes looking at their hydropathy and charge, asJournal of Biomedicine and Biotechnology 5
Table 3: Amino acids classes considered with respect to their
hydropathyandcharge.Everyrowshowstheidentiﬁcationclassand
the amino acids components.
Class Amino Acids
I ILE-VAL-LEU
II PHE-CYS-MET-ALA
III GLY-THR-SER-TRP-TYR-PRO
IV HIS-GLN-ASN
V GLU-ASP
VI LYS-ARG
shown in Table 3. Every amino acid belonging to the center
of bond is assumed to be invariant in the motif, while the
others residues (except proline) belonging to the binding site
are variable within their class, as deﬁned inTable 3.I nc a s eo f
proline, its structure do not allow the movement of the bond
between the α carbon and the nitrogen of the backbone,
blocking the rotation of the chain; as a consequence, the
substitution of the proline with any other aminoacid could
inﬂuence the stability of the interaction. The secondary
structures of the interactors, as extracted from the PDB ﬁles
of the protein complexes, are also considered to compute of
the structural motifs.
The obtained motifs of the example sequence (Table 2)i s
therefore
[I/V/L] P [K/R] SN[R/K][ K/R]
HHLL LL L (1)
where loops (L) and alpha chains (H) are reported.
Finally, we assign a score to every motif according to the
following rules: every unchanged residue is scored 20, while
every variable amino acid is scored as the ratio between 20
and the number of allowed variations.
Then, the ﬁnal score of the motif (motif score, ScoreM)
is computed by multiplying the single scores of the
aminoacids. For example, the score of the sequence motif
[IVL]P[KR]SN[RK][RK] is: (20/3)×20×(20/2)×20×20×
(20/2) ×(20/2) = 5.33 ×107.
2.4. Searching for the Interacting Motifs in the Potential Inter-
actors: Score3 and Score4. We search for both the sequence
and structuralmotifs in all the predicted interactors. Because
the secondary structure is unknown for the majority of
the potential interactors, three of the most used tools
for secondary structure prediction, that is, PREDATOR,
NNPREDICT and NPS [41–43], are employed. All these
algorithms assign to every amino acid a secondary structure
as loop (L), alpha chain (H) and beta sheet (E). Therefore,
w ec o m p u t eas c o r ef o re v e r yi n t e r a c t o rI of the list PINT as
Score3(I) = max
 
ScoreMI
length
 
sequence(I)
 
 
,( 2 )
where ScoreMI is the list of motif scores of the interactor I.
Finally, assuming that a single motif is not suﬃcient
to determine an interaction, it is also important to take
into account how many complete interaction sites (sets of
binding sites belonging to an interface between two chains)
are present. For this reason, we deﬁne another score related
to the subset of the motifs of the interactor I belonging to an
interaction site
Score4(I) =
 
 
Score
 MI
length
 
sequence(I)
 
 
,( 3 )
where Score
 MI is the list of motif scores of the interactor I
belonging to an interaction site that includes all the motifs.
2.5. Final Score Calculation. Once the four scores are com-
puted, we calculate a normalised ﬁnal score, which expresses
ameasureofthelikelihoodthatapotentialinteractorisareal
interactor of the target protein.
Score(I) =
4  
j=1
⎛
⎝ Scorej(I)
max
 
Scorej(I)
 
⎞
⎠. (4)
3. Results
The proposed procedure was tested by using the growth
factorreceptor-boundprotein2(GRB2)asthetargetprotein.
Moreover, a validation approach was applied (seeSection
3.6) to evaluate the accuracy and precision of the procedure
and to choose a suitable score threshold to predict new
interactors.
3.1. Database Search of GRB2 Interactors. We initially
retrieved 21 known structures of protein complexes contain-
ing GRB2 main domains (i.e., SH2 and SH3).
The list of potential interactors (PINT) was then
obtained by retrieving from HPRD database 46 in vitro
discovered interactors. We also retrieved from the same
database 141 interactors in vivo validated, which together
with the sequences of the proteins extracted from the 21
GRB2 complexes, formed a list of 247 conﬁrmed interactors
(CINT).
3.2. Alignment with the Conﬁrmed Interactors: Score1 and
Score2. Each PINT member was aligned with CINT coun-
terparts, evaluating Score1 for the best alignments. Next,
every potential interactor was aligned with the conserved
regions of the conﬁrmed ones, computed with ConSurf, thus
obtaining the values of Score2 (Table 4).
3.3. Extraction of the Interaction Motifs from the Protein
Complexes. We extracted binding sites for every interface
between GRB2 and the diﬀerent chains of each of the
21 retrieved complexes. We found 190 diﬀerent interac-
tion motifs, with scores ranging from a minimum of 20
(single aminoacid motifs) to a maximum of 1.58 × 1011
(R[HQN]QQ[IVL][FCMA][IVL][KR][ED][IVL]E motif).
3.4. Searching for the Interacting Motifs in the Potential Inter-
actors: Score3 and Score4. We searched for the interacting
motifs in the PINT list and we selected, for each potential6 Journal of Biomedicine and Biotechnology
Table 4: Overview of the scores used to rank the putative GRB2 interactors. NCBI protein accession number, Score1,S c o r e 2,t h es e q u e n c e
and the structure conﬁguration of the best motif, Score3 and Score4, were reported. The last column showed the ﬁnal score assigned to each
interactor.
Access number Score1 Score2 Best motif of sequence Best struct. motif Score3 Number int. sites Score4 Final score
NP 001306 344.7 2378 PPP[IVL] LLLL 148.1 27 181.2 2.52
NP 003014 4 2177 PPP[IVL] LLLL 95 12 168 2.33
NP 060910 −11.3 1774 PPP[IVL]P LLLLL 2469.1 18 8.9 2.21
NP 004432 1688.3 3910 [ED]D[ED] LLL 2 31 14.5 2.08
NP 004407 −43.3 2468 PPP[IVL] LLLL 86 22 92.2 2.02
NP 003713 −40.3 2417 PPP[IVL] LLLL 78.4 24 87 1.99
NP 005145 −52.3 3370 [ED]N[IVL] LLL 1.2 34 15.1 1.98
NP 002030 −2.3 2269 PPP[IVL] LLLL 76.8 21 83.3 1.95
NP 002511 −3.7 1220 [ED]ED[ED] LLLL 136 20 151.8 1.9
NP 005148 29.3 3261 [ED]N[IVL] LLL 1.2 24 4.9 1.88
NP 003311 −25 2204 [ED]ED[ED] LLLL 71.3 26 81.6 1.86
NP 003362 1032.3 3399 [ED]D[ED] LLL 2.4 24 7 1.86
NP 006566 798 3359 [ED]D[ED] LLL 2.4 27 9.9 1.84
NP 149129 −24.7 3141 [HQN][KR]S[GTSWYP][GTSWYP] HLLLL 18.7 11 20.1 1.82
NP 005556 93.7 2141 [ED]ED[ED] LLLL 75 12 77 1.8
NP 036252 11.3 2472 PPP[IVL] LLLL 83.5 26 94.1 1.76
NP 003806 516.3 3112 [IVL]N[IVL] LLL 1 22 8.3 1.76
NP 001973 955.7 1960 [ED]ED[ED] LLLL 29.8 31 40.6 1.75
NP 004439 1297.3 2468 [ED]D[ED] LLL 1.6 32 11.7 1.73
NP 612401 −50.3 2223 PPP[IVL] LLLL 75.4 11 77 1.73
NP 542179 −19.3 2370 PPP[IVL] LLLL 91 27 103.9 1.72
NP 004680 −47.7 2296 RR[KR] LLL 5.6 23 8.2 1.57
NP 002244 1179 1981 [HQN]Q[HQN] LLL 0.6 30 6.7 1.55
NP 002960 297.7 2304 [ED]D[ED] LLL 5.4 14 20.5 1.55
NP 000689 −36.3 2377 [KR]D[GTSWYP] ELL 1 25 8.6 1.5
NP 005875 258.7 2345 RR[KR] LLL 6.8 13 12.6 1.5
NP 114098 −10.7 2370 [ED]D[ED] LLL 3 20 8.9 1.49
NP 036428 −14.7 2471 G[GTSWYP]F LLL 2 18 4.8 1.48
NP 066189 237.7 2526 [GTSWYP]E[IVL] LLE 0.7 9 1.1 1.48
NP 000869 −4.7 2251 RR[KR] LLL 7.2 26 11.7 1.44
NP 005222 −22.3 2246 [ED]D[ED] LLL 3.6 21 7.9 1.42
NP 055413 −20.7 2313 [KR]D[GTSWYP] ELL 1.1 8 0.6 1.42
NP 065795 −33.3 2166 RR[KR] LLL 7.8 18 6.1 1.35
NP 000732 106.7 1894 [IVL]N[HQN] LLL 1.8 16 4.9 1.28
NP 002637 −144.7 186 PPP[IVL] LLLL 32.6 31 40.8 1.27
NP 000675 347.7 1831 [ED]D[ED] LLL 4.2 10 1.2 1.25
NP 001773 −28.7 1520 [ED]N[IVL] LLL 3.7 13 22 1.23
NP 003170 −24.3 1300 [ED]N[IVL] LLL 4.2 21 31.6 1.21
NP 006454 −18.7 1727 [GTSWYP]K[ED] HLL 1.6 17 6.5 1.19
NP 000013 −26.7 1523 [GTSWYP]E[KR] LLE 1.8 19 10.2 1.17
NP 057627 −28 1540 [GTSWYP]S[IVL] LLL 1.2 13 4.2 1.12
NP 689901 219.3 1436 [GTSWYP]E[KR] LLE 1.9 17 8.9 1.1
NP 004030 −34.3 1448 [GTSWYP]S[IVL] LLL 1.3 9 1.3 1.09
NP 955359 376 1292 [ED]D[ED] LLL 6.3 10 7.9 1.06
NP 542417 −207.7 −4169 [GTSWYP]RP[IVL]P LLLLL 82.4 26 110.2 1.03
NP 002342 591 538 [KR]D[GTSWYP] ELL 5.2 6 3.4 0.77Journal of Biomedicine and Biotechnology 7
interactor, the one with the highest score.Table 4 highlighted
the sequence, the structural conﬁguration and the score
(Score3) of the motif with the highest ranking. By grouping
the motifs belonging to the same interface between two
chains, we found 76 interaction sites. Table 4 showed the
number and the sum of the calculated scores only for the
motifs belonging to an interaction site (Score4).
3.5. Final Score Calculation. The ﬁnal score of each of the 46
possible GRB2 interactors was computed as the normalized
sum of all the scores, as illustrated in Table 4.
3.6. Validation of the Proposed Method. To test the method-
ology, a dataset made of 10 GRB2 true (conﬁrmed)
and 10 false (not conﬁrmed, randomly chosen proteins)
interactors was employed; the ﬁnal scores were computed
for each simulated interaction. To perform an unbiased
comparison, we removed the positive interactors from the
CINT sequences. Then, we applied a “Leave-one-out” cross-
validation procedure by considering each time a diﬀerent
protein as the unique “test” case and the remaining as
“training set”. We then applied a simple classiﬁer, obtained
by computing the best threshold (Th) on the scores of the
training set to maximize the Information Gain (IG):
IG =−
2  
c=1
p(c)log2p(c)
+
2  
T Score=1
p(TScore)
2  
c=1
p(cT Score)log2(cT Score),
(5)
where c was the class of the protein (conﬁrmed interac-
tors/not interacting proteins) and TScore a binary variable
such that
T Score = 0, ifScore ≤ Th,
T Score = 1, if Score > Th.
(6)
As a result, the mean accuracy of the Leave-one-out proce-
dure was 75%, and the mean precision was 86%.
Finally, we calculated the median value of the thresholds
obtained in the leave-one-out process (i.e., 1.63); this
value was then used to select 21 proteins with the highest
probabilitytobeGRB2interactors:amongthese,theisoform
1 of the mitogen-activated protein kinase 14 (MAPK14) had
the highest probability score.
4. Discussion
We have developed a novel algorithm for prediction of
protein-proteininteractionsthatcombinesstructuresimilar-
ity and sequence conservation of protein complex interfaces.
The performance of the algorithm was tested on the
ability to predict GRB2-interacting proteins. GRB2 is a small
adapting protein composed of a SH2 and two SH3 domains.
This protein plays a very important role in the process
of signal transduction, as a mediator between the growth
factors receptors at the cellular membrane level and the
cytosolic RAS proteins. In particular, the mitosis promoting
signal, stimulated by the epidermal growth factor (EGF),
requires the tyrosine kinase activity, originated by speciﬁc
trans membrane receptors (EGRFs). Starting from these
receptors, the activation of RAS consists in a cascade of
protein interactions that involves the GRB2/SOS-1 complex.
Diﬀerent sites of auto phosphorylation in the C-terminal
region of EGFRs are binding sites for the SH2 domain of
GRB2, while its SH3 domains mediate the recruitment of the
exchange factor SOS-l, inducing the subsequent activation of
RAS proteins. Then, RAS lead to a cascade that ends with the
nuclear translocation of phosphorylated MAP kinase, which
then activates transcription factors [44].
After our bioinformatics prediction, we ranked a set
of 46 potential GRB2 interactors according to their scores,
which we assumed to be putative interactors with the target
protein. Resorting to a score threshold chosen by means of
a cross-validation strategy, we further screened 21 of the
most probable interactors. Among these, MAPK14 had the
highest probability score of interaction with GRB2. MAPKs
are a group of serine/threonine kinases, activated in response
to many extracellular stimuli and mediating diﬀerent sig-
nal transduction pathways. Four diﬀerent MAPKs families
were identiﬁed in mammalian cells: extracellular signal-
regulated kinase (ERK), c-Jun N-terminal kinase/stress-
activated protein kinase (JNK/SAPK), ERK5/big MAP kinase
1(BMK1)andMAPKp38.Inparticular,MAPKp38proteins
are involved in growth regulation, cellular diﬀerentiation,
apoptosis, cellular response to inﬂammation and stress [45].
This subfamily is composed of four members (α, β, γ and
δ) and MAPK14 is the isoform α, that together with β,i s
ubiquitary expressed [46]. To further conﬁrm our in silico
prediction, the MAPK14-GRB2 interaction was previously
in vitro observed using the GST pull-down technique [47].
In particular, this study hypothesized that in platelets p38α
bind to the SH2 domain of GRB2 in response to stimulation
mediated by activation of FcγRIIA (CD32) receptor. This
association could act by carrying the cytosolic GRB2, with its
complexed proteins, towards speciﬁc subcellular topologies,
driving the complex to speciﬁc substrates [47].
At a structural level, the best motif found for MAPK14-
GRB2 interaction was PPP[IVL]; this motif was also iden-
tiﬁed as an interacting site, because in the in silico extracted
complex(1GBQ),itallowedtheSH3domaintobindtoSOS-
1 protein.
However,globalalignmentsbetweenGRB2andMAPK14
protein sequences did not directly reveal a contribution
of the above mentioned motif: diﬀerently, three motifs,
extracted from complexes in which the SH2 domain of
GRB2 was involved, were aligned (i.e., PF, [ED]N[IVL]
and [IVL]K). These motifs were localized in Pro58-Phe59,
Glu81-Asn82-Val83, and Leu151-Lys152 in MAPK14 protein
tertiarystructure;asreportedinFigure 3, a similar structural
topology of the residues Pro56-Phe57, Glu79-Asn80-Ile81,
and Leu148-Lys149 was highlighted for ERK2, a tyrosine
kinase which has been in vivo conﬁrmed to interact with
GRB2 [48].8 Journal of Biomedicine and Biotechnology
For this reason, it was possible to predict that MAPK14,
as well as ERK2, can interact with the SH2 domain of GRB2,
probably through the above mentioned amino acids.
In summary, the method herein proposed is a ﬁrst
step to the deﬁnition of a bioinformatics tool to support
experimental studies on protein interactions. According
to the validation procedure performed, the accuracy and
precision of this method were 75% and 86%, respectively.
These results might suggest that the proposed bioinformatics
approach can be eﬀectively applied to preliminary screen
a wide set of protein interactants, such as those deriving
from two hybrids systems, to select those to be primarily
investigated.
Currently, the main limitations of our method are the
small number of complexes with known structures and the
relatively poor knowledge on conﬁrmed interactors.
To overcome these limits, we are working on future
reﬁnements of the method, in particular on exploiting the
available bioinformatics and database knowledge to deﬁne
diﬀerent levels of prediction.
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